Calcium-Involved Action of Phytochemicals: Carotenoids and Monoterpenes in the Brain

Int J Mol Sci. 2020 Feb 20;21(4):1428. doi: 10.3390/ijms21041428.

Abstract

Background: Neurodegenerative and mood disorders represent growing medical and social problems, many of which are provoked by oxidative stress, disruption in the metabolism of various neurotransmitters, and disturbances in calcium homeostasis. Biologically active plant compounds have been shown to exert a positive impact on the function of calcium in the central nervous system.

Methods: The present paper reviews studies of naturally occurring terpenes and derivatives and the calcium-based aspects of their mechanisms of action, as these are known to act upon a number of targets linked to neurological prophylaxis and therapy.

Results: Most of the studied phytochemicals possess anticancer, antioxidative, anti-inflammatory, and neuroprotective properties, and these have been used to reduce the risk of or treat neurological diseases.

Conclusion: The neuroprotective actions of some phytochemicals may employ mechanisms based on regulation of calcium homeostasis and should be considered as therapeutic agents.

Keywords: NMDA; VGCC; calcium; carotenoids; monoterpenes; neuroprotection; retinoic acid.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain* / metabolism
  • Brain* / pathology
  • Calcium / metabolism*
  • Carotenoids / therapeutic use*
  • Humans
  • Monoterpenes / therapeutic use*
  • Mood Disorders* / drug therapy
  • Mood Disorders* / metabolism
  • Mood Disorders* / pathology
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / metabolism
  • Neurodegenerative Diseases* / pathology
  • Neuroprotective Agents / therapeutic use*
  • Phytochemicals / therapeutic use*

Substances

  • Monoterpenes
  • Neuroprotective Agents
  • Phytochemicals
  • Carotenoids
  • Calcium